Phase II Study of Irinotecan and Panitumumab

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Weijing Sun, MD, FACP, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00836277
First received: February 3, 2009
Last updated: January 29, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)